Bundibugyo Ebolavirus 2026: Cross-Border Outbreak in DRC and Uganda
WHO confirmed a Bundibugyo ebolavirus outbreak spanning DRC and Uganda on 16 May 2026 — the first since 2012. This article covers the strain's history, current spread, and why cross-border coordination is critical.
A Rare Strain Returns After 14 Years
On 16 May 2026, the World Health Organization published a Disease Outbreak News report confirming an outbreak of Ebola disease caused by Bundibugyo virus affecting both the Democratic Republic of the Congo (Ituri Province) and Uganda (Bundibugyo District, Western Region). It is the first confirmed Bundibugyo ebolavirus outbreak since 2012 — and the first ever to be confirmed as cross-border from the outset.
As of 20 May 2026, 21 cases and 7 deaths have been confirmed across both countries (case fatality rate: 33%). The DRC accounts for the majority of cases (15 cases, 4 deaths), with Uganda reporting 6 confirmed cases and 3 deaths. A further 12 suspected cases are under investigation.
What Is Bundibugyo Ebolavirus?
Bundibugyo ebolavirus (BDBV) is one of five species in the Orthoebolavirus genus. It was first identified in 2007 during an outbreak in Bundibugyo District, Uganda, where 149 people were infected and 37 died (CFR: 25%). A second and smaller outbreak struck Isiro, DRC in 2012, infecting 36 people and killing 13 (CFR: 36%).
Compared to Zaire ebolavirus — the strain responsible for the largest and deadliest outbreaks, including the 2014–2016 West Africa epidemic — Bundibugyo typically produces a lower case fatality rate (historic average ~25–36%). However, this does not mean it is less dangerous in practice: the lower CFR may partly reflect different surveillance conditions, and the clinical course remains severe.
Key characteristics of Bundibugyo ebolavirus:
| Feature | Bundibugyo | Zaire |
|---|---|---|
| CFR (historic) | 25–36% | 50–90% |
| Approved vaccine | ❌ None | ✅ rVSV-ZEBOV (Ervebo) |
| Approved treatment | ❌ None | ✅ Inmazeb, Ebanga |
| Outbreaks since 1976 | 3 (2007, 2012, 2026) | 15+ |
| Natural reservoir | Unknown (likely bats) | Unknown (likely bats) |
This is a critical point: there is no approved vaccine or specific antiviral treatment for Bundibugyo ebolavirus. The widely-stockpiled rVSV-ZEBOV (Ervebo) vaccine works only against Zaire strain. Monoclonal antibodies Inmazeb and Ebanga are also Zaire-specific.
2026 Outbreak: What We Know
Origin
The index case is believed to have had exposure in a border forest area between Ituri Province (DRC) and Bundibugyo District (Uganda) in late April 2026. The DRC Ministry of Health and the Institut National de Recherche Biomédicale (INRB) in Kinshasa confirmed the first cases by RT-PCR on 10 May 2026, with WHO’s Disease Outbreak News published on 16 May.
Geographic Spread
The outbreak straddles a historically porous border in the Albertine Rift region:
- DRC side: Ituri Province, specifically the border health zones adjacent to Uganda
- Uganda side: Bundibugyo District (the same district where BDBV was first discovered in 2007), Western Region
Epidemiological Situation (as of 20 May 2026)
- Total cases: 21 confirmed (15 DRC, 6 Uganda)
- Total deaths: 7 (4 DRC, 3 Uganda)
- Contacts under monitoring: 534 across both countries
- Healthcare worker infections: None confirmed to date
The Cross-Border Challenge
Cross-border Ebola outbreaks present fundamentally different operational challenges than single-country events. The DRC–Uganda border in this region is highly permeable: communities maintain extensive family, social, and trade ties across the frontier. Several contact chains are believed to involve movement between countries.
Coordinating a joint response requires:
- Harmonised case definitions between two different national health systems
- Shared contact lists and cross-border contact tracing protocols
- Border health posts capable of screening and referring suspected cases
- Diplomatic coordination for movement of response personnel and supplies
Uganda activated its Emergency Operations Centre on 17 May 2026. WHO is convening regular inter-country coordination calls. Africa CDC is providing cross-border technical support.
Uganda’s Advantage: Recent Experience
Uganda has responded to six Sudan virus disease outbreaks since 2000 and maintains experienced rapid response teams and well-practised community engagement networks. Its most recent outbreak — the 2025 SVD event — ended just 24 days before the Bundibugyo outbreak was declared, meaning Uganda’s response infrastructure was still at heightened readiness.
Treatment and Research Outlook
With no approved vaccine or therapeutic for BDBV, clinical management relies entirely on supportive care: aggressive fluid and electrolyte replacement, treatment of secondary infections, and management of organ failure. Mortality outcomes depend heavily on how early patients reach an Ebola Treatment Unit (ETU).
Experimental approaches under consideration include:
- Broad-spectrum monoclonal antibodies (such as MBP134, under research) that may have cross-reactive activity against BDBV
- Convalescent plasma from 2007 and 2012 survivors, if available
- Candidate BDBV vaccines in early-stage development (none yet in efficacy trials)
The 2026 outbreak will likely accelerate calls for BDBV-specific countermeasure development and renewed investment in pan-ebolavirus platforms.
What Happens Next
WHO has not yet assessed this event as a Public Health Emergency of International Concern (PHEIC), but the cross-border nature and lack of available countermeasures mean the situation is being monitored at the highest level. Key indicators to watch:
- Growth rate of the contact list — a rapidly expanding contact network suggests undetected transmission chains
- Urban spread — Bunia (DRC, pop. ~800,000) and Fort Portal (Uganda) are within the wider outbreak zone; any spread to urban centres would significantly complicate containment
- Healthcare worker infections — a leading indicator of nosocomial amplification
EbolaMap will continue updating case counts and geographic data as confirmed reports are published.
Sources: WHO Disease Outbreak News (16 May 2026), DRC Ministry of Health, Uganda Ministry of Health, Africa CDC. All case counts represent confirmed cases only.